Valuation
publishLooking for the best stocks based on fundamental valuation metrics? The Stocklytics Valuation Screener simplifies your search by ranking stocks in ascending order of price-to-earnings (PE) ratio, helping you identify undervalued opportunities at a glance.
| name | arrow_upwardPE RATIO | PRICE | $ CHANGE | % CHANGE | MARKET CAP | PEG (TTM) | P/S | P/B | P/CF | P/FCF | EV | EV/EBIT | EV/ EBITDA | EV/R | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AKBAAkebia Therapeutics | - | $1.37 | $0.00 | 0.00% | $288.09M | 0.00 | 1.65 | 4.11 | - | - | 296.00M | -8.42 | 63.94 | 1.69 | AI Analysis | |||
MPAAMotorcar Parts of America | - | $6.01 | -$0.24 | arrow_drop_down3.84% | $122.07M | 0.55 | 0.16 | 0.45 | 3.17 | 3.29 | 368.69M | 10.83 | 8.35 | 0.50 | AI Analysis | |||
PTNPalatin Technologies | - | $1.28 | -$0.01 | arrow_drop_down0.77% | $26.34M | 0.00 | 4.46 | 15.82 | - | - | 15.67M | -0.49 | -0.64 | 2.65 | AI Analysis | |||
CLDXCelldex Therapeutics | - | $41.24 | $0.08 | arrow_drop_up0.19% | $2.73B | 0.00 | 328.60 | 3.40 | - | - | 1.974B | - | -17.34 | 237.77 | AI Analysis | |||
BNEDBarnes & Noble Education | - | $9.79 | -$1.52 | arrow_drop_down13.43% | $256.57M | 1.10 | 0.18 | 2.05 | - | - | 790.15M | 89.15 | 97.34 | 0.50 | AI Analysis | |||
ELYMEliem Therapeutics | - | $8.43 | $0.15 | arrow_drop_up1.81% | $565.31M | - | 0.00 | 2.49 | 9,917.85 | 9,917.85 | 332.21M | - | 0.58 | 0.00 | AI Analysis | |||
YTRAYatra Online | - | $1.60 | $0.00 | arrow_drop_up0.58% | $96.11M | 1.12 | 0.02 | 1.53 | 0.49 | 0.55 | 47.01M | - | 51.28 | 0.95 | AI Analysis | |||
INOInovio Pharmaceuticals | - | $6.48 | -$0.21 | arrow_drop_down3.13% | $168.24M | 0.00 | 297.43 | 1.81 | - | - | 78.33M | -0.60 | -1.09 | 132.35 | AI Analysis | |||
MBINMMerchants Bancorp - Depositary Shares, Each Representing a 1/40th Interest in a Share of 8.25% Fixed-Rate Reset Series D Non-Cumulative Perpetual Preferred Stoc | - | $26.53 | -$0.19 | arrow_drop_down0.71% | _ | - | 0.00 | 0.00 | - | - | 2.073B | 27.49 | 0.00 | 0.00 | AI Analysis | |||
 AFRMAffirm Holdings | - | $44.93 | -$0.05 | arrow_drop_down0.11% | $13.97B | - | 6.02 | 5.12 | 26.69 | 41.31 | 18.457B | - | -45.40 | 7.94 | AI Analysis | |||
FNGRFingerMotion | - | $2.07 | -$0.12 | arrow_drop_down5.47% | $109.11M | - | 3.41 | 10.68 | - | - | 116.17M | - | -8.07 | 3.63 | AI Analysis | |||
RELYRemitly Global | - | $14.13 | -$0.12 | arrow_drop_down0.84% | $2.79B | - | 2.57 | 4.80 | - | - | 2.625B | - | -33.69 | 2.42 | AI Analysis | |||
 RIGTransocean Ltd | - | $4.54 | $0.00 | 0.00% | $4.00B | -22.91 | 1.29 | 0.37 | 39.35 | - | 10.826B | - | 13.91 | 3.51 | AI Analysis | |||
AKTSAkoustis Technologies | - | $0.06 | $0.00 | arrow_drop_up1.47% | $7.53M | 0.00 | 0.24 | 0.17 | - | - | 36.59M | -0.40 | -1.54 | 1.22 | AI Analysis | |||
ITCIIntra-Cellular Therapies | - | $77.61 | $0.64 | arrow_drop_up0.83% | $7.89B | 0.00 | 14.40 | 7.10 | - | - | 7.128B | - | -37.12 | 12.65 | AI Analysis | |||
WVEWaVe Life Sciences Ltd | - | $5.68 | -$0.26 | arrow_drop_down4.37% | $708.51M | 0.00 | 6.70 | 27.11 | - | - | 616.48M | -7.17 | -10.11 | 5.57 | AI Analysis | |||
APAmpco-Pittsburgh | - | $2.11 | -$0.18 | arrow_drop_down7.86% | $42.39M | 0.00 | 0.10 | 0.75 | 16.06 | - | 175.62M | 24.87 | 9.52 | 0.40 | AI Analysis | |||
SMTISanara MedTech | - | $32.11 | -$1.19 | arrow_drop_down3.57% | $280.86M | - | 4.02 | 6.52 | - | - | 282.24M | - | -29.02 | 3.89 | AI Analysis | |||
REEREE Automotive Ltd. | - | $5.76 | -$0.02 | arrow_drop_down0.34% | $63.53M | - | 35.39 | 0.88 | - | - | 23.74M | -0.20 | 0.52 | 13.43 | AI Analysis | |||
SNOASonoma Pharmaceuticals | - | $3.46 | -$0.37 | arrow_drop_down9.66% | $3.54M | 0.00 | 0.30 | 0.79 | - | - | 1.79M | -0.38 | -0.16 | 0.14 | AI Analysis |
Showing 1401-1420 of 1478
Results per page:
Looking for the best stocks based on fundamental valuation metrics? The Stocklytics Valuation Screener simplifies your search by ranking stocks in ascending order of price-to-earnings (PE) ratio, helping you identify undervalued opportunities at a glance.
Our screener doesn’t stop at PE ratio. We dive deep into additional critical metrics that matter for smarter investments:
- PEG Ratio – Evaluate stocks with growth factored in for a more complete view.
- Price-to-Sales (P/S) Ratio – Identify stocks priced attractively relative to their revenue.
- Price-to-Book (P/B) Ratio – Find opportunities by comparing a company’s market value with its book value.
- Price-to-Cash Flow (P/CF) Ratio – Gauge how well a company generates cash compared to its stock price.
- Price-to-Free Cash Flow (P/FCF) Ratio – Discover companies generating healthy free cash flow, a key indicator of financial health.
We also provide enterprise valuation insights through metrics such as:
- Enterprise Value (EV) – A holistic view of a company’s total valuation.
- EV/EBIT – Focus on the core earnings without accounting distortions.
- EV/EBITDA – Evaluate profitability before depreciation and amortization.
- EV/Revenue – See how a company’s enterprise value stacks up against revenue.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools